WHO ICTRP trial

A double blind, double dummy, multicenter, randomized, placebo- and…

CTIS2024-512292-12-00 · EU Clinical Trials Information System · Recruiting

Key facts

Trial ID CTIS2024-512292-12-00
Public title A double blind, double dummy, multicenter, randomized, placebo- and active-controlled clinical trial to evaluate effectiveness of Tricortin 1000 in patients affected by chronic low back pain
Scientific title A double blind, double dummy, multicenter, randomized, placebo- and active-controlled clinical trial to evaluate effectiveness of Tricortin 1000 in patients affected by chronic low back pain - EQ06.17.01
Primary sponsor Fidia Farmaceutici S.p.A.
Registry EU Clinical Trials Information System
Recruitment status Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes
Countries Italy
Conditions Low Back Pain MedDRA version: 21.0Level: LLTClassification code: 10052430Term: Chronic lumbago Class: 10028395;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
Interventions Product Name: ITAMI 140 mg cerotto medicato, Product Code:PRD3355726, Pharmaceutical Form: MEDICATED PLASTER, Other descriptive name: , Strength: , Product Name: Placebo 1 - injectable solution, Product Code:N/A, Pharmaceutical Form: N/A…
Registration date Sep 10, 2024
Target size 300
Secondary IDs NCT04585334;2018-002003-33
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations